In this study, we confirmed this hypothesis by highlighting a novel mechanism by which MYC can directly control both ITGA6 and ESRP2 promoter activities in CRC cells, leading to the overexpression of the pro-proliferative ITGA6A splice variant. This evidence concerns the gene ESRP2 and colorectal carcinoma.